74 related articles for article (PubMed ID: 10635646)
21. [Thus to avoid complications of diabetes. To combine early].
MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732409
[No Abstract] [Full Text] [Related]
22. [Postprandial blood glucose as the driving force in pathogenesis of type 2 diabetes].
Liebl A
Med Klin (Munich); 2003 Oct; 98 Suppl 1():7-11. PubMed ID: 14694835
[TBL] [Abstract][Full Text] [Related]
23. The addition of acarbose to insulin lispro reduces acute glycaemic responses in patients with type-2 diabetes.
Hermanns N; Burkert A; Haak T
Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):310-4. PubMed ID: 15216448
[TBL] [Abstract][Full Text] [Related]
24. Antihyperglycaemic and antiperoxidative roles of acarbose in type 2 diabetes mellitus are possibly mediated through changes in thyroid function.
Rameshwar J; Anand K
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1104-6. PubMed ID: 17042922
[TBL] [Abstract][Full Text] [Related]
25. Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes.
Juntti-Berggren L; Pigon J; Hellström P; Holst JJ; Efendic S
Diabetes Nutr Metab; 2000 Feb; 13(1):7-12. PubMed ID: 10824717
[TBL] [Abstract][Full Text] [Related]
26. [Role of acarbose in the treatment of diabetes mellitus].
Scheen AJ
Diabetes Metab; 1998 Sep; 24(4):385-90. PubMed ID: 9805654
[No Abstract] [Full Text] [Related]
27. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
[No Abstract] [Full Text] [Related]
28. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
Rosak C; Haupt E; Walter T; Werner J
Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
[TBL] [Abstract][Full Text] [Related]
29. [Acarbose can slow down beginning of type 2 diabetes].
Lanzendörfer C
Dtsch Med Wochenschr; 2003 Jan; 128(4):162; discussion 162. PubMed ID: 12589591
[No Abstract] [Full Text] [Related]
30. [Already in altered glucose tolerance an antidiabetic drug. Significantly fewer heart attacks].
MMW Fortschr Med; 2003 Jan; 145(3-4):57. PubMed ID: 12619238
[No Abstract] [Full Text] [Related]
31. Combination therapy for postprandial and orthostatic hypotension in an elderly patient with type 2 diabetes mellitus.
Yamamoto N; Sasaki E; Arishima T; Ito M; Tanaka H; Terasaki J; Imagawa A; Hanafusa T
J Am Geriatr Soc; 2006 Apr; 54(4):727-8. PubMed ID: 16686900
[No Abstract] [Full Text] [Related]
32. [Late diagnosis. Only after infarct is diabetes detected].
MMW Fortschr Med; 2004 Jan; 146(5):51. PubMed ID: 15035427
[No Abstract] [Full Text] [Related]
33. Managing type 2 diabetes. A look at the newer agents.
Larmore SS
JAAPA; 1999 Jun; 12(6):47-8, 51-4, 57. PubMed ID: 10728087
[No Abstract] [Full Text] [Related]
34. Preventive treatment with acarbose in diabetic reactive hypoglycemia.
Lee A
J Am Med Dir Assoc; 2010 Jun; 11(5):377-8. PubMed ID: 20511106
[No Abstract] [Full Text] [Related]
35. Acarbose for patients with hypertension and impaired glucose tolerance.
Rosenthal JH
JAMA; 2003 Dec; 290(23):3066; author reply 3067-9. PubMed ID: 14679262
[No Abstract] [Full Text] [Related]
36. Acarbose: an alternative to metformin for first-line treatment in type 2 diabetes?
Ma RC
Lancet Diabetes Endocrinol; 2014 Jan; 2(1):6-7. PubMed ID: 24622656
[No Abstract] [Full Text] [Related]
37. Acarbose vs metformin for new-onset type 2 diabetes.
Gallo M; Candido R; De Micheli A; Esposito K; Gentile S; Ceriello A;
Lancet Diabetes Endocrinol; 2014 Feb; 2(2):104. PubMed ID: 24622707
[No Abstract] [Full Text] [Related]
38. Acarbose vs metformin for new-onset type 2 diabetes.
Tsujimoto T; Yamamoto-Honda R
Lancet Diabetes Endocrinol; 2014 Feb; 2(2):104-5. PubMed ID: 24622706
[No Abstract] [Full Text] [Related]
39. [Acarbose and insulin dependent diabetes, type 1].
Gabriel Botella F; Galindo Puerto MJ
An Med Interna; 1996 Dec; 13(12):618. PubMed ID: 9063950
[No Abstract] [Full Text] [Related]
40. Acarbose for type 2 diabetes prevention.
Mühlhauser I
Lancet; 2002 Nov; 360(9344):1517; author reply 1517. PubMed ID: 12433559
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
